Rapid Micro Biosystems, Inc. (NASDAQ:RPID) CEO Sells $39,476.97 in Stock

Rapid Micro Biosystems, Inc. (NASDAQ:RPID - Get Free Report) CEO Robert G. Jr. Spignesi sold 11,247 shares of the business's stock in a transaction on Wednesday, July 9th. The stock was sold at an average price of $3.51, for a total transaction of $39,476.97. Following the completion of the transaction, the chief executive officer directly owned 900,583 shares in the company, valued at $3,161,046.33. This trade represents a 1.23% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link.

Rapid Micro Biosystems Price Performance

Shares of RPID stock traded down $0.10 during mid-day trading on Thursday, hitting $3.37. The company had a trading volume of 68,661 shares, compared to its average volume of 196,931. Rapid Micro Biosystems, Inc. has a 52-week low of $0.63 and a 52-week high of $4.04. The stock's 50 day moving average price is $3.29 and its 200-day moving average price is $2.55. The company has a market capitalization of $147.71 million, a P/E ratio of -3.27 and a beta of 1.32.

Rapid Micro Biosystems (NASDAQ:RPID - Get Free Report) last released its quarterly earnings results on Friday, May 9th. The company reported ($0.26) earnings per share for the quarter, beating the consensus estimate of ($0.27) by $0.01. Rapid Micro Biosystems had a negative return on equity of 56.07% and a negative net margin of 151.22%. The company had revenue of $7.21 million for the quarter, compared to analyst estimates of $6.63 million. On average, equities research analysts expect that Rapid Micro Biosystems, Inc. will post -1.1 earnings per share for the current year.

Institutional Investors Weigh In On Rapid Micro Biosystems

Hedge funds and other institutional investors have recently made changes to their positions in the company. American Century Companies Inc. purchased a new stake in shares of Rapid Micro Biosystems in the first quarter valued at $31,000. Legato Capital Management LLC purchased a new position in Rapid Micro Biosystems in the 1st quarter worth about $41,000. Millennium Management LLC increased its stake in Rapid Micro Biosystems by 17.6% in the 4th quarter. Millennium Management LLC now owns 61,375 shares of the company's stock worth $55,000 after buying an additional 9,191 shares during the period. Essex Investment Management Co. LLC purchased a new position in Rapid Micro Biosystems in the 1st quarter worth about $166,000. Finally, Citadel Advisors LLC purchased a new position in Rapid Micro Biosystems in the 4th quarter worth about $65,000. Hedge funds and other institutional investors own 52.60% of the company's stock.

About Rapid Micro Biosystems

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.